COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis

Patwary, Muhammad M. and Alam, Md Ashraful and Bardhan, Mandira and Disha, Asma S. and Haque, Md. Zahidul and Billah, Sharif M. and Kabir, Md Pervez and Browning, Matthew H. E. M. and Rahman, Md. Mizanur and Parsa, Ali D. and Kabir, Russell (2022) COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis. Vaccines, 10. p. 427. ISSN 2076-393X

[img]
Preview
Text
Published Version
Available under the following license: Creative Commons Attribution.

Download (3MB) | Preview
Official URL: http://dx.doi.org/10.3390/vaccines10030427

Abstract

Widespread vaccination against COVID-19 is critical for controlling the pandemic. Despite the development of safe and efficacious vaccinations, low-and lower-middle income countries (LMICs) continue to encounter barriers to care owing to inequitable access and vaccine apprehension. This study aimed to summarize the available data on COVID-19 vaccine acceptance rates and factors associated with acceptance in LMICs. A comprehensive search was performed in PubMed, Scopus, and Web of Science from inception through August 2021. Quality assessments of the included studies were carried out using the eight-item Joanna Briggs Institute Critical Appraisal tool for cross-sectional studies. We performed a meta-analysis to estimate pooled acceptance rates with 95% confidence intervals (CI). A total of 36 studies met the inclusion criteria and were included in the review. A total of 83,867 respondents from 33 countries were studied. Most of the studies were conducted in India (n = 9), Egypt (n = 6), Bangladesh (n = 4), or Nigeria (n = 4). The pooled-effect size of the COVID-19 vaccine acceptance rate was 58.5% (95% CI: 46.9, 69.7, I2 = 100%, 33 studies) and the pooled vaccine hesitancy rate was 38.2% (95% CI: 27.2–49.7, I2 = 100%, 32 studies). In country-specific sub-group analyses, India showed the highest rates of vaccine acceptancy (76.7%, 95% CI: 65.8–84.9%, I2= 98%), while Egypt showed the lowest rates of vaccine acceptancy (42.6%, 95% CI: 16.6–73.5%, I2= 98%). Being male and perceiving risk of COVID-19 infection were predictors for willingness to accept the vaccine. Increasing vaccine acceptance rates in the global south should be prioritized to advance global vaccination coverage.

Item Type: Journal Article
Keywords: Vaccine Hesitancy, COVID-19, Meta Analysis, Vaccine, SARS-COV-2
Faculty: COVID-19 Research Collection
Faculty of Health, Education, Medicine & Social Care
SWORD Depositor: Symplectic User
Depositing User: Symplectic User
Date Deposited: 15 Mar 2022 11:13
Last Modified: 27 Apr 2022 09:39
URI: https://arro.anglia.ac.uk/id/eprint/707397

Actions (login required)

Edit Item Edit Item